BCM
CALC icon

BML Capital Management’s CalciMedica CALC Stock Holding History

BML Capital Management’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-153,887
Closed -$682K – 27
2024
Q3 		$682K Sell
153,887
-6,537
-4% -$28.7K 0.4% 22
2024
Q2 		$635K Hold
160,424
– – 0.45% 23
2024
Q1 		$667K Buy
160,424
+15,000
+10% +$68.5K 0.44% 28
2023
Q4 		$416K Buy
145,424
+56,643
+64% +$164K 0.32% 33
2023
Q3 		$236K Hold
88,781
– – 0.22% 24
2023
Q2 		$356K Buy
+88,781
New +$388K 0.32% 26
2023
Q1 		– Sell
-88,282
Closed -$618K – 32
2022
Q4 		$618K Buy
+88,282
New +$990K 0.59% 20

Other funds holding CALC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

BML Capital Management's CALC Position: Q4 2024 in Review

BML Capital Management sold out of CalciMedica (CALC) in Q4 2024, closing a stake of 153,887 shares — an estimated $682K sold.

BML Capital Management first reported a position in CALC in Q4 2022 and held it in 7 quarters. The position peaked at $682K in Q3 2024. 29 funds tracked by Wall St. Rank hold CALC as of Q4 2024.

  • BML Capital Management reported no remaining CalciMedica position as of Q4 2024 after selling out during the quarter.
  • BML Capital Management sold 153,887 CalciMedica shares in Q4 2024, an estimated $682K.
  • BML Capital Management first reported a position in CalciMedica in Q4 2022 and held it in 7 quarters.
  • BML Capital Management's CalciMedica position peaked at $682K in Q3 2024.
  • 29 funds tracked by Wall St. Rank held CalciMedica as of Q4 2024.

Based on BML Capital Management's 13F filing for Q4 2024, filed 7 Feb 2025.